Ignite Creation Date:
2025-12-24 @ 9:19 PM
Ignite Modification Date:
2025-12-29 @ 8:55 PM
Study NCT ID:
NCT00845104
Status:
WITHDRAWN
Last Update Posted:
2015-03-06
First Post:
2009-02-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Fludarabine Phosphate, Rituximab, and Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Relapsed or Not Responded To Treatment
Sponsor:
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2278.00
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Pagel, John
Old Organization:
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium